SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yingnan Huang, Hao Wu, Shengdi Wu, Da Fu, Yushui Ma, Xizhong Shen, A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B, Digestive Diseases and Sciences, 2013, 58, 3, 815

    CrossRef

  2. You have free access to this content2
    Federico G. Villamil, Fernando M. Cairo, Hepatitis B virus: Prevention of recurrent infection, Clinical Liver Disease, 2013, 2, 4
  3. 3
    Seyfettin Köklü, Yaşar Tuna, Murat Taner Gülşen, Mehmet Demir, Aydin Şeref Köksal, Muhammet Cem Koçkar, Cem Aygün, Şahin Çoban, Kamil Özdil, Hüseyin Ataseven, Ebru Akin, Tuğrul Pürnak, İlhami Yüksel, Hilmi Ataseven, Mehmet İbiş, Beytullah Yildirim, Işilay Nadir, Metin Küçükazman, Erdem Akbal, Osman Yüksel, Ömer Başar, Erhan Alkan, Özlem Baykal, Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus–Related Cirrhosis, Clinical Gastroenterology and Hepatology, 2013, 11, 1, 88

    CrossRef

  4. 4
    Wai-Kay Seto, Man-Fung Yuen, James Fung, Ching-Lung Lai, Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection, Hepatology International, 2013, 7, 2, 327

    CrossRef

  5. 5
    Y.J. Jung, B.G. Kim, J.S. Kim, W. Kim, J.-H. Yoon, H.-S. Lee, N.-J. Yi, K.-W. Lee, K.-S. Suh, Y.J. Kim, The Effect of Pretransplantation Lamivudine Resistance on the Prognosis of Liver Transplant Recipients, Transplantation Proceedings, 2013, 45, 1, 231

    CrossRef

  6. 6
    Bruno Roche, Didier Samuel, Treatment of Patients with HBV-related Decompensated Cirrhosis and Liver Transplanted Patients, Clinics in Liver Disease, 2013, 17, 3, 451

    CrossRef

  7. 7
    Alexander Kuo, Robert Gish, Chronic Hepatitis B Infection, Clinics in Liver Disease, 2012, 16, 2, 347

    CrossRef

  8. 8
    Jong Jin Hyun, Yeon Seok Seo, Eileen Yoon, Tae Hyung Kim, Dong Jin Kim, Hyun Seok Kang, Eun Suk Jung, Jeong Han Kim, Hyonggin An, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Hong Sik Lee, Kwan Soo Byun, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu, Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis, Liver International, 2012, 32, 4
  9. You have free access to this content9
    A. K. Singal, R. J. Fontana, Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis, Alimentary Pharmacology & Therapeutics, 2012, 35, 6
  10. 10
    Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten, The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation, Langenbeck's Archives of Surgery, 2012, 397, 5, 697

    CrossRef

  11. 11
    Steven-Huy Han, K. Rajender Reddy, Emmet B. Keeffe, Consuelo Soldevila-Pico, Robert Gish, Raymond T. Chung, Bulent Degertekin, Anna Lok, Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study, Clinical Transplantation, 2011, 25, 2
  12. 12
    Vincenza Calvaruso, Antonio Craxì, Fibrosis in chronic viral hepatitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 219

    CrossRef

  13. 13
    Mortada H.F. El-Shabrawi, Naglaa M. Kamal, Medical Management of Chronic Liver Diseases in Children (Part I), Pediatric Drugs, 2011, 13, 6, 357

    CrossRef

  14. 14
    Josh Levitsky, Olaf Guckelberger, Meeting Report of the 16th Annual International Congress of the International Liver Transplantation Society, Liver Transplantation, 2011, 17, 1
  15. 15
    J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2715

    CrossRef

  16. 16
    Richard Guan, Hock Foong Lui, Treatment of Hepatitis B in Decompensated Liver Cirrhosis, International Journal of Hepatology, 2011, 2011, 1

    CrossRef

  17. 17
    Markus Peck-Radosavljevic, Johann Deutsch, Peter Ferenci, Ivo Graziadei, Harald Hofer, Heidemarie Holzmann, Wolf-Dietrich Huber, Herman Laferl, Andreas Maieron, Rudolf Stauber, Wolfgang Vogel, 4. Österreichischer Konsensusbericht zur Diagnose und Therapie der Hepatitis B 2009, Wiener klinische Wochenschrift, 2010, 122, 9-10, 280

    CrossRef

  18. 18
    Hui-Hui Tan, Paul Martin, Management of End-Stage Liver Disease in Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 477

    CrossRef

  19. 19
    JULES L. DIENSTAG, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  20. 20
    MARGARET JAMES KOZIEL, CHLOE LYNNE THIO, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  21. 21
    Jules L. Dienstag, Benefits and risks of nucleoside analog therapy for hepatitis B, Hepatology, 2009, 49, S5
  22. 22
    Susanne Beckebaum, Georgios C. Sotiropoulos, Guido Gerken, Vito R. Cicinnati, Hepatitis B and liver transplantation: 2008 update, Reviews in Medical Virology, 2009, 19, 1
  23. 23
    A. Mas, Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis, Digestive and Liver Disease, 2009, 41, S191

    CrossRef

  24. 24
    W. Ray Kim, Norah A. Terrault, Rachel A. Pedersen, Terry M. Therneau, Erick Edwards, Andrew A. Hindman, Carol L. Brosgart, Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States, Gastroenterology, 2009, 137, 5, 1680

    CrossRef

  25. 25
    M. Berenguer, A. Palau, V. Aguilera, J.-M. Rayón, F. S. Juan, M. Prieto, Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation, American Journal of Transplantation, 2008, 8, 3
  26. 26
    Badar Muneer, Giuliano Testa, J M. Millis, Smruti R. Mohanty, Entecavir Therapy in a Hepatitis B-Related Decompensated Cirrhotic Patient, Southern Medical Journal, 2008, 101, 11, 1173

    CrossRef

  27. 27
    Jules L. Dienstag, Hepatitis B Virus Infection, New England Journal of Medicine, 2008, 359, 14, 1486

    CrossRef

  28. 28
    Fabien Zoulim, Sylvie Radenne, Christian Ducerf, Management of patients with decompensated hepatitis B virus associated cirrhosis, Liver Transplantation, 2008, 14, S2
  29. 29
    Reiichiro Kuwahara, Ryukichi Kumashiro, Tatsuya Ide, Yuriko Koga, Teruko Hino, Akiko Hisamochi, Kazuo Tanaka, Kei Ogata, Hiroyuki Koga, Yukari Takao, Michio Sata, Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV, Digestive Diseases and Sciences, 2008, 53, 11, 2999

    CrossRef

  30. 30
    Z. Mesut Yalin Kilic, Sedef Kuran, Meral Akdogan, Bahattin Cicek, Dilek Oguz, Bulent Odemis, Nurgul Sasmaz, The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis, Advances in Therapy, 2008, 25, 3, 190

    CrossRef

  31. 31
    Eugene Schiff, Ching-Lung Lai, Stephanos Hadziyannis, Peter Neuhaus, Norah Terrault, Massimo Colombo, Hans Tillmann, Didier Samuel, Stefan Zeuzem, Jean-Pierre Villeneuve, Sarah Arterburn, Katyna Borroto-Esoda, Carol Brosgart, Steven Chuck, Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results, Liver Transplantation, 2007, 13, 3
  32. 32
    Miquel Navasa, Xavier Forns, Antiviral therapy in HCV decompensated cirrhosis: To treat or not to treat?, Journal of Hepatology, 2007, 46, 2, 185

    CrossRef

  33. 33
    Mark W Russo, Current concepts in the evaluation of patients for liver transplantation, Expert Review of Gastroenterology & Hepatology, 2007, 1, 2, 307

    CrossRef

  34. 34
    Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal, Hepatitis B and End-Stage Liver Disease, Clinics in Liver Disease, 2007, 11, 4, 893

    CrossRef

  35. 35
    Claire Francoz, Jacques Belghiti, François Durand, Indications of liver transplantation in patients with complications of cirrhosis, Best Practice & Research Clinical Gastroenterology, 2007, 21, 1, 175

    CrossRef

  36. 36
    Melissa K. Osborn, Steven H. Han, Arie Regev, Natalie H. Bzowej, Michael B. Ishitani, Tram T. Tran, Anna S.F. Lok, Outcomes of Patients With Hepatitis B Who Developed Antiviral Resistance While on the Liver Transplant Waiting List, Clinical Gastroenterology and Hepatology, 2007, 5, 12, 1454

    CrossRef

  37. 37
    J. Prada Lobato, S. Garrido López, M.A. Catalá Pindado, F. García Pajares, Profilaxis de reinfección por el virus de la hepatitis B postrasplante hepático, Farmacia Hospitalaria, 2007, 31, 1, 30

    CrossRef

  38. 38
    Nam-Joon Yi, Kyung-Suk Suh, Jai Young Cho, Choon Hyuck Kwon, Kwang-Woong Lee, Jae Won Joh, Suk-Koo Lee, Soon Il Kim, Kuhn Uk Lee, Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation, Liver Transplantation, 2007, 13, 3
  39. 39
    Chantal Haché, Jean-Pierre Villeneuve, Lamivudine treatment in patients with chronic hepatitis B and cirrhosis, Expert Opinion on Pharmacotherapy, 2006, 7, 13, 1835

    CrossRef

  40. You have free access to this content40
    Yasuhiko Sugawara, Masatoshi Makuuchi, Liver transplantation for hepatitis B-related cirrhosis: recent advances, Journal of Hepato-Biliary-Pancreatic Surgery, 2006, 13, 5
  41. 41
    Morris Sherman, Optimizing Management Strategies in Special Patient Populations, The American Journal of Gastroenterology, 2006, 101, S1, S26

    CrossRef

  42. 42
    Norah A. Terrault, Jonathan T. Carter, Laurie Carlson, Michelle E. Roland, Peter G. Stock, Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation, Liver Transplantation, 2006, 12, 5
  43. 43
    Christoph Eisenbach, Peter Sauer, Arianeb Mehrabi, Wolfgang Stremmel, Jens Encke, Prevention of hepatitis B virus recurrence after liver transplantation, Clinical Transplantation, 2006, 20,
  44. 44
    Didier Samuel, Prise en charge de la résistance à la lamivudine en transplantation hépatique pour hépatopathie B, Gastroentérologie Clinique et Biologique, 2006, 30, 10, 26

    CrossRef

  45. 45
    Cengiz Bolukbas, Fusun Filiz Bolukbas, Tulin Kendir, Nihat Akbayir, Ali Tuzun Ince, Evren Abut, Mehmet Horoz, Ali Remzi Dalay, Mehmet Haci Sokmen, Oya Ovunc, The Effectiveness of Lamivudine Treatment in Cirrhotic Patients with HBV Precore Mutations: A Prospective, Open-Label Study, Digestive Diseases and Sciences, 2006, 51, 7, 1196

    CrossRef

  46. 46
    Bruno Roche, Didier Samuel, Transplantation hépatique pour hépatopathies B chroniques, La Presse Médicale, 2006, 35, 2, 335

    CrossRef

  47. 47
    Po-lin Tseng, Sheng-Nan Lu, Hung-Da Tung, Jing-Houng Wang, Chi-Sin Changchien, Chuan-Mo Lee, Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis, Journal of Viral Hepatitis, 2005, 12, 4
  48. 48
    Hari S. Conjeevaram, Disease status and therapeutic end points in hepatitis B, Current Hepatitis Reports, 2005, 4, 1, 5

    CrossRef

  49. 49
    Nikolaos Nikolaidis, Themistoklis Vassiliadis, Olga Giouleme, Konstantinos Tziomalos, Nikolaos Grammatikos, Kalliopi Patsiaoura, Eleni Orfanou-Koumerkeridou, Aikaterini Balaska, Nikolaos Eugenidis, Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B, Clinical Transplantation, 2005, 19, 3
  50. 50
    D. R. Snydman, B. Y. Tung, K. V. Kowdley, Hepatitis B and Liver Transplantation, Clinical Infectious Diseases, 2005, 41, 10, 1461

    CrossRef

  51. 51
    Abduljaleel Al Alwan, Leslie B. Lilly, Liver transplantation for HBV and management of reinfection, Current Hepatitis Reports, 2005, 4, 1, 39

    CrossRef

  52. 52
    Anna S. F. Lok, Liver transplantation for patients with lamivudine-resistant HBV: What is the optimal prophylactic strategy?, Liver Transplantation, 2005, 11, 5
  53. 53
    Scott K. Fung, Anna S.F. Lok, Management of patients with hepatitis B virus-induced cirrhosis, Journal of Hepatology, 2005, 42, 1, S54

    CrossRef

  54. 54
    Pratima Sharma, Jorge Rakela, Management of pre-liver transplantation patients—Part 1, Liver Transplantation, 2005, 11, 2
  55. 55
    Pratima Sharma, Jorge Rakela, Management of pre–liver transplantation patient—Part 2, Liver Transplantation, 2005, 11, 3
  56. 56
    Norah Terrault, Bruno Roche, Didier Samuel, Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective, Liver Transplantation, 2005, 11, 7
  57. 57
    Bruno Roche, Didier Samuel, Prévention et traitement de l’hépatite B après transplantation hépatique, Gastroentérologie Clinique et Biologique, 2005, 29, 4, 393

    CrossRef

  58. 58
    Teresa C. Taltavull, Nadia Chahri, Blanca Verdura, Joan Gornals, Carmen Lopez, Aurora Casanova, Concha Cañas, Juan Figueras, Luis A. Casais, Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results, Transplant International, 2005, 18, 7
  59. 59
    Jules L. Dienstag, The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B, Journal of Hepatology, 2005, 42, 2, 158

    CrossRef

  60. 60
    Bruno Roche, Didier Samuel, Treatment of hepatitis�B and C after liver transplantation. Part 1, hepatitis�B, Transplant International, 2005,

    CrossRef

  61. 61
    BRUNO ROCHE, DIDIER SAMUEL, Transplantation of the Liver, 2005,

    CrossRef

  62. 62
    PRATIMA SHARMA, HUGO E. VARGAS, JORGE RAKELA, Transplantation of the Liver, 2005,

    CrossRef

  63. 63
    Cindy J. Lai, Norah A. Terrault, Antiviral therapy in patients with chronic hepatitis B and cirrhosis, Gastroenterology Clinics of North America, 2004, 33, 3, 629

    CrossRef

  64. 64
    Spilios Manolakopoulos, Stylianos Karatapanis, Jiannis Elefsiniotis, Nicoletta Mathou, Jiannis Vlachogiannakos, Elissabet Iliadou, Anastasios Kougioumtzan, Michalis Economou, Christos Triantos, Dimitrios Tzourmakliotis, Alec Avgerinos, Clinical Course of Lamivudine Monotherapy in Patients with Decompensated Cirrhosis due to HBeAg negative chronic HBV infection, The American Journal of Gastroenterology, 2004, 99, 1, 57

    CrossRef

  65. 65
    Peter Karayiannis, Current therapies for chronic hepatitis B virus infection, Expert Review of Anti-infective Therapy, 2004, 2, 5, 745

    CrossRef

  66. 66
    Bruno Roche, Didier Samuel, Evolving strategies to prevent HBV recurrence, Liver Transplantation, 2004, 10, S10
  67. 67
    F.Fred Poordad, Liver transplant and recurrent disease, Clinics in Liver Disease, 2004, 8, 2, 461

    CrossRef

  68. 68
    Robert J. Fontana, Management of Decompensated HBV Cirrhosis: Lamivudine and Beyond, The American Journal of Gastroenterology, 2004, 99, 1, 64

    CrossRef

  69. 69
    W. Ray Kim, John J. Poterucha, Walter K. Kremers, Michael B. Ishitani, E. Rolland Dickson, Outcome of liver transplantation for hepatitis B in the United States, Liver Transplantation, 2004, 10, 8
  70. 70
    Bruno Roche, Didier Samuel, Transplantation and prevention of reinfection, Current Hepatitis Reports, 2004, 3, 2, 67

    CrossRef

  71. 71
    Bruno Roche, Didier Samuel, Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B, Transplant International, 2004, 17, 12
  72. 72
    Bruno Roche, Didier Samuel, Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results, Journal of Hepatology, 2003, 39, 181

    CrossRef

  73. 73
    Mary Ann Huang, Anna S.F Lok, Natural history of hepatitis b and outcomes after liver transplantation, Clinics in Liver Disease, 2003, 7, 3, 521

    CrossRef

  74. 74
    Andy S Yu, Emmet B Keeffe, Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period, Clinics in Liver Disease, 2003, 7, 3, 551

    CrossRef

  75. 75
    Daniel Seehofer, Nada Rayes, Peter Neuhaus, Prophylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era, Expert Review of Anti-infective Therapy, 2003, 1, 2, 307

    CrossRef

  76. 76
    Federico G Villamil, Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection, Journal of Hepatology, 2003, 39, 4, 466

    CrossRef

  77. 77
    Robert J. Fontana, Anna S.F. Lok, Combination of HBIG and lamivudine-resistant mutations: A formula for trouble?, Liver Transplantation, 2002, 8, 11